Behaviour of vaginal epithelial maturation and sex hormone binding globulin in post-menopausal breast cancer patients during the first year of tamoxifen therapy

Cytopathology

Volumn 9, Issue 4, 1998, Pages 263-270

  Bertolissi, A ^a,b   Cartei, G ^a   Turrin, D ^b   Cioschi, B ^a   Rizzi, V ^a  

^a Department of Oncology   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Anti oestrogens; Breast cancer; Karyopyknotic index; Maturation index; Sex hormone binding globulin; Tamoxifen

Indexed keywords

ESTROGEN; SEX HORMONE BINDING GLOBULIN; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CELL MATURATION; EPIGASTRIC PAIN; ESTROGEN SYNTHESIS; FEMALE; HOT FLUSH; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NAUSEA; POSTMENOPAUSE; PRIORITY JOURNAL; VAGINA EPITHELIUM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN; TAMOXIFEN; TIME FACTORS; VAGINA;

EID: 0031904759     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.1998.00077.x     Document Type: Article

References (33)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1-15, 71-85.
2. Legha SS. Tamoxifen in the treatment of breast cancer. Ann Int Med 1988; 109: 219-28.
3. Kangas L. Agonistic and antagonistic effects of anti-oestrogens in different target organs. Acta Oncologica 1992; 3: 143-6.
4. Love R. Tamoxifen therapy in primary breast cancer. Biology, efficacy, and side effects. J Clin Oncol 1989; 7: 803-15.
5. Osborne CK, Boldy DH, Clark GM et al. Effects of tamoxifen in human breast cancer cells kinetics: accumulation of cells in early GI phase. Cancer Res 1983; 43: 3583-5.
6. Sutherland RN, Green MD, Hall RE et al. Tamoxifen induces accumulation of MCF7 human mammary carcinoma cells in the GO-GI phase of the cell cycle. Eur J Cancer Clin Oncol 1983; 19: 615-21.
7. Gulino A, Barrera G, Vacca A et al. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene anti-oestrogens in MCF7 human breast cancer cells. Cancer Res 1986; 46: 6274-8.
8. Benry J, Green BJ, Matheson DS. Modulation of natural killer cell activity by tamoxifen in stage 1 post menopausal breast cancer. Eur J Cancer Clin Oncol 1987; 23: 517-20.
9. Friedl A, Jordan VC. The role of prolonged antihormonal treatment of breast cancer. A strategy for adjuvant therapy. In: Ragaz J, Ariel IM, eds. High Risk Breast Cancer Therapy. Berlin: Springer Verlag, 1981; 163-83.
10. Nayfield SG, Karp JE, Ford LG, Dorr FA, Kramer BS. Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 1991; 83: 1450-9.
11. Miograg A, Ekelund P, Burton R, Castleden CM. Tamoxifen and partial oestrogen agonism in postmenopausal women. Age and Ageing 1991; 20: 52-4.
12. Fornander T, Rutquist LE, Wilking N, Caristrom K, von Schoultz B. Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer. Eur J Cancer 1993; 29: 497-500.
13. Szamel I, Vincze B, Hindy I et al. Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer. Oncology 1986; 43: 7-11.
14. Boccardo F, Guarnieri D, Rubagotti A et al. Endocrine effect of tamoxifen in postmenopausal breast cancer patients. Tumori 1984; 70: 61-8.
15. Cartei G, Venza E. Effect of Tamoxifen on serum copper, ceruloplasmin, transferrin, karyopyknotic and maturative index of bladder trigone cell in males with cancer (Abstract). 2nd Int Symp Antihormones Breast Cancer. Berlin: 21-24 October 1984.
16. Cartei G, Daniele O, Chiarion Sileni V, Fiorentino M. Effect of Tamoxifen on serum Cu and ceruloplasmin in 228 patients with breast cancer (Abstract). 2nd Int Symp Antihormones Breast Cancer. Berlin: 21-24 October 1984.
17. Athanassiadou PP, Kirkou KA, Antoniades LG, Athanassiades PH. Cytological evaluation of the effect of Tamoxifen in premenopausal and postmenopausal women with primary breast cancer by analysis of the karyopyknotic indices of vaginal smears. Cytopathology 1992; 3: 203-8.
18. Eells TP, Alpern HD, Grzywacz C, MacMillan RW, Olson JE. The effect of Tamoxifen on cer vical squamous maturation in Papanicolaou stained cervical smears of postmenopausal women, Cytopathology 1990; 1: 263-8.
19. Boccardo F, Bruzzi P, Rubagotti P, Nicolò G, Rosso R. Oestrogen-like action of Tamoxifen on vaginal epithelium in breast cancer patients. Oncology 1981; 38: 281-5.
20. Ferrazzi E, Cartei G, Mattarazzo R, Fiorentino M. Oestrogen-like action of Tamoxifen on vaginal epithelium. Br Med J 1977; 1: 1351-2.
21. Powles TJ. Tamoxifen therapy and carcinogenic risk. J Nutl Cancer Inst 1995; 87: 1343-5.
22. Musa BU, Seal US, Doe RP. Elevation of certain plasma proteins in man following oestrogen administration: a dose response relationship. J Clin Endocr Metab 1965; 25: 1163-6.
23. Vermeulen A, Verdonck L, Van der Straeten M, Orie N. Capacity of the testosterone-binding-globulin in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J Clin Endocr Metab 1969; 29: 1470-80.
24. Soost HJ, Baur S. Citodiagnostica Ginecologica. Padova: Piccin, 1985: 40.
25. Lahti E, Vuopala S, Kauppila A et al. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen. Gynecol Oncol 1994; 55: 410-4.
26. Koss LG. Cytologic evaluation of the endocrine status of the woman. In: Koss LG, ed. Diagnostic Cytology and its Histopathologic Basis, 2nd edn. Philadelphia: JB Lippincott, 1968: 127-42.
27. Helgason S. Oestrogen replacement therapy after the menopause. Oestrogenicity and metabolic effects. Acta Obst Gynecol Scand 1982; 107 (Suppl): 7-29.
28. Sakai F, Cheix F, Clavel M et al. Increases in steroid binding globulin induced by tamoxifen in patients with carcinoma of breast. J Endocr 1978; 76: 219-26.
29. Love RR, Kurtycz DF, Yang FC. The effects tamoxifen on the vaginal epithelium in postmenopausal women (Abstract). Proc Am Soc Clin Oncol 1996; 15: 103.
30. Lonning PE, Johannessen DC, Lien EA et al. Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients. J Steroid Biochem Molec Biol 1995; 52: 491-6.
31. Jordan VC, Fritz NF, Tormey DC. Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III. Cancer Res 1987; 47: 4517-9.
32. Fornander T, Hellström AC, Moberger B. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer. J Natl Cancer Inst 1993; 85: 1850-5.
33. Ingle JM. Tamoxifen and endometrial cancer: new challenges for an 'old' drug. Gynecol Oncol 1994; 55: 161-3.